Schonfeld Strategic Advisors LLC Harmony Biosciences Holdings, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 9,346 shares of HRMY stock, worth $325,708. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,346Holding current value
$325,708% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding HRMY
# of Institutions
226Shares Held
45.4MCall Options Held
48.2KPut Options Held
61.5K-
Valor Management LLC Chicago, IL11.2MShares$391 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$203 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$123 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$90.8 Million11.62% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.51MShares$87.5 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.06B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...